GPR30 decreases cardiac chymase/angiotensin II by inhibiting local mast cell number

Biochemical and Biophysical Research Communications

Volumn 459, Issue 1, 2015, Pages 131-136

  Zhao, Zhuo ^a,b   Wang, Hao ^a   Lin, Marina ^a   Groban, Leanne ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Chymase; Estrogen; GPR30; Heart; Mast cell

Indexed keywords

ANGIOTENSIN II; CHYMASE; CYCLIN DEPENDENT KINASE 1; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR 30; MESSENGER RNA; 1-(4-(6-BROMOBENZO(1,3)DIOXOL-5-YL)-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA(C)QUINOLIN-8-YL)ETHANONE; CDK1 PROTEIN, RAT; CYCLIN DEPENDENT KINASE; CYCLOPENTANE DERIVATIVE; ESTROGEN; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, RAT; QUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL COUNTING; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART PROTECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEWIS RAT; MAST CELL; NONHUMAN; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; AGONISTS; ANIMAL; CARDIAC MUSCLE; CELL LINE; CYTOLOGY; DRUG EFFECTS; METABOLISM; OVARIECTOMY; PHYSIOLOGY;

RATTUS;

ANGIOTENSIN II; ANIMALS; CELL LINE; CELL PROLIFERATION; CHYMASES; CYCLIN-DEPENDENT KINASES; CYCLOPENTANES; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONISTS; ESTROGENS; FEMALE; MAST CELLS; MYOCARDIUM; OVARIECTOMY; QUINOLINES; RATS, INBRED LEW; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84930179081     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.082     Document Type: Article

References (27)

1. K. Prabhavathi, K.T. Selvi, and K.N. Poornima Role of biological sex in normal cardiac function and in its disease outcome - a review J. Clin. Diagn. Res. 8 2014 BE01 BE04
2. Z. Zhao, H. Wang, and J.A. Jessup Role of estrogen in diastolic dysfunction Am. J. Physiol. Heart. Circ. Physiol. 306 2014 H628 H640
3. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, Heart and Estrogen/progestin Replacement Study (HERS) research group JAMA 280 1998 605 613
4. D. Grady, D. Herrington, and V. Bittner Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
5. L.L. Schierbeck, L. Rejnmark, and C.L. Tofteng Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial BMJ 345 2012 e6409
6. E.J. Filardo, and P. Thomas GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release Trends. Endocrinol. Metab. 16 2005 362 367
7. E.R. Prossnitz, J.B. Arterburn, and L.A. Sklar GPR30: a G protein-coupled receptor for Estrogen Mol. Cell. Endocrinol. 265-266 2007 138 142
8. A.M. Deschamps, and E. Murphy Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats Am. J. Physiol. Heart. Circ. Physiol. 297 2009 H1806 H1813
9. M. Delbeck, S. Golz, and R. Vonk Impaired left-ventricular cardiac function in male GPR30-deficient mice Mol. Med. Rep. 4 2011 37 40
10. J.A. Jessup, S.H. Lindsey, and H. Wang Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats PLoS One 5 2010 e15433
11. H. Wang, J.A. Jessup, and M.S. Lin Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats Cardiovasc. Res. 94 2012 96 104
12. X. Xu, J.C. Xiao, and L.F. Luo Effects of ovariectomy and 17beta-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial ultrastructure Int. J. Cardiol. 130 2008 196 204
13. H. Wang, J.A. Jessup, and Z. Zhao Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats PLoS One 8 2013 e76992
14. M.C. Chappell, P.E. Gallagher, and D.B. Averill Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat Hypertension 42 2003 781 786
15. J.A. Jessup, H. Wang, and L.M. MacNamara Estrogen therapy, independent of timing, improves cardiac structure and function in oophorectomized mRen2.Lewis rats Menopause 20 2013 860 868
16. J. Li, S. Jubair, and J.S. Janicki Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling Hypertension 65 2015 328 334
17. L.J. Dell'Italia, and A. Husain Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases Curr. Opin. Cardiol. 17 2002 374 379
18. M. Miyazaki, S. Takai, and D. Jin Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models Pharmacol. Ther. 112 2006 668 676
19. A. Vivacqua, D. Bonofiglio, and A.G. Recchia The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells Mol. Endocrinol. 20 2006 631 646
20. L. Albanito, A. Madeo, and R. Lappano G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells Cancer. Res. 67 2007 1859 1866
21. J. Teng, Z.Y. Wang, and E.R. Prossnitz The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation Endocrinology 149 2008 4024 4034
22. B.C. Lin, M. Suzawa, and R.D. Blind Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation Cancer. Res. 69 2009 5415 5423
23. E. Passante, and N. Frankish The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell Inflamm. Res. 58 2009 737 745
24. T.C. Theoharides, D. Kempuraj, and M. Tagen Differential release of mast cell mediators and the pathogenesis of inflammation Immunol. Rev. 217 2007 65 78
25. J.A. Stewart Jr., C.C. Wei, and G.L. Brower Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog J. Mol. Cell. Cardiol. 35 2003 311 319
26. J. Li, H. Lu, and E. Plante Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart J. Mol. Cell. Cardiol. 53 2012 469 474
27. N. Arizono, T. Shiota, and M. Yamada Bromodeoxyuridine labeling studies on the proliferation of intestinal mucosal mast cells in normal and athymic rats APMIS 98 1990 369 376